Stoxline.com

Stock Symbol:   

Stoxline Mobile
Home  |  Stock Charts  |  Showcases  |  Stock Ranks  |  Options  |  ETFs  |  Educations

The Greenrose Holding Company Inc. (GNRS)

0.6   0.19 (46.31%) 11-25 11:14
Open: 0.38 Pre. Close: 0.4101
High: 0.6 Low: 0.38
Volume: 3,201 Market Cap: 11(M)

Technical analysis

as of: 2022-11-25 1:57:28 PM
Overall:       
Stoxline posted a BUY today, upgraded from lower rating. Upward movement to be expected.
Target: Six months: 0.92     One year: 1.27
Support: Support1: 0.31    Support2: 0.26
Resistance: Resistance1: 0.79    Resistance2: 1.09
Pivot: 0.72
Moving Average: MA(5): 0.56     MA(20): 0.81
MA(100): 1.68     MA(250): 2.66
MACD: MACD(12,26): -0.2     Signal(9): -0.2
Stochastic oscillator: %K(14,3): 20.8     %D(3): 11.2
RSI: RSI(14): 36.4
52-week: High: 7.59  Low: 0.31
Average Vol(K): 3-Month: 4 (K)  10-Days: 1 (K)

Price, moving averages and Bollinger Bands

Price has closed above its short-term moving average. Short-term moving average is currently below mid-term; and below long-term moving average. From the relationship between price and moving averages: This stock is NEUTRAL in short-term; and BEARISH in mid-long term.
[ GNRS ] has closed above bottom band by 32.7%. Bollinger Bands are 17.4% narrower than normal. The current width of the bands does not suggest anything about the future direction or movement of prices.

Stock Price Prediction

Update at 5:00pm EST
If tomorrow: Open lower Open higher
High: 0.41 - 0.41 0.41 - 0.41
Low: 0.4 - 0.41 0.41 - 0.41
Close: 0.41 - 0.41 0.41 - 0.41

Company Description

Greenrose Holding Company Inc., through its subsidiaries, engages in the production and sale of cannabis products. It engages in cultivating, processing, and packaging medical cannabis and derivative products. The company was founded in 2014 and is headquartered in Amityville, New York.

Headline News

Fri, 11 Nov 2022
Pancreatic tumor microenvironmental acidosis and hypoxia transform gold nanorods into cell-penetrant particles for potent radiosensitization - Science

Mon, 22 Aug 2022
The Greenrose Holding Company Inc.'s (GNRS) CEO Mickey Harley on Q2 2022 Results - Earnings Call Transcript - Seeking Alpha

Thu, 19 May 2022
The Greenrose Holding Company sees 1Q revenue bump from acquisition of True Harvest - Proactive Investors USA

Mon, 09 May 2022
Unraveling the Peeling and Sliding of Graphene Nanoribbons - AZoNano

Fri, 06 May 2022
Researchers Explore the Effects of Manipulating Graphene Nanoribbons - AZoM

Thu, 03 Feb 2022
'32 Ford Scores 2022 Grand National Roadster Show Al Slonaker Award - MotorTrend

Financial Analysis

Price to Book Value: Outperform
P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly.
Price to Earnings: Neutral
PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS).
Discounted cash flow: Outperform
DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows.
Return on Assets: Underperform
ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit.
Return on Equity: Underperform
ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency.
Debt to Equity: Outperform
evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn.
Free Technical Analysis Charts

Stock Basics & Statistics

Exchange:  PNK
Sector:  Healthcare
Industry:  Drug Manufacturers—Specialty & Generic
Shares Out. 18 (M)
Shares Float 7 (M)
% Held by Insiders 71.7 (%)
% Held by Institutions 18.2 (%)
Shares Short 291 (K)
Shares Short P.Month 131 (K)

Stock Financials

EPS 3.09
EPS Est Next Qtl 0
EPS Est This Year 0
EPS Est Next Year 0
Book Value (p.s.) 0.81
Profit Margin (%) 47.3
Operating Margin (%) -146
Return on Assets (ttm) -14.8
Return on Equity (ttm) 346.2
Qtrly Rev. Growth 25.8
Gross Profit (p.s.) 1.05
Sales Per Share 1.6
EBITDA (p.s.) -0.66
Qtrly Earnings Growth 0
Operating Cash Flow -63 (M)
Levered Free Cash Flow -12 (M)

Stock Valuations

PE Ratio 0.19
PEG Ratio 0
Price to Book value 0.73
Price to Sales 0.37
Price to Cash Flow -0.17

Stock Dividends

Dividend 0
Forward Dividend 0
Dividend Yield 0%
Dividend Pay Date Invalid DateTime.
Ex-Dividend Date Invalid DateTime.
Your Ad Here
android_stock_chart
StockChart iOS
stoxline_lite
StoxlineLite iOS
stoxline_pro
StoxlineLite iOS
Option_Calculator
OptionCalc iOS
android_stock_chart
StockChart Android
stoxline_lite
StoxlineLite Android
stoxline_pro
StoxlinePro Android
Option_Calculator
OptionCalc Android
(c) 2006-2022 Stoxline.com | Contact us           
Data and information is provided for informational purposes only, and is not intended for trading purposes. Neither Stoxline.com nor its data provider shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon. By accessing the Stoxline.com web site, a user agrees not to redistribute the information found therein.